Remedy Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on the development and commercialization of small molecule drugs for acute central nervous system disorders including stroke, traumatic brain injury, and spinal cord injury.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/10/14 | undisclosed |
Broadview Ventures | undisclosed | |
| 12/02/15 | $9,000,000 |
Ed Woolard Vertical Group | undisclosed |
